Tritium-labeled cytochalasin B binds rapidly and reversibly t o mammalian cells, and a class of high-affinity sites (K, (KD 2 lo-' M) are detected. In red blood cells, the high-affinity binding sites (about 3 X 10' per cell) are associated with the plasma membrane, and at least 80% of these appear t o be intimately related to the glucose transport system. Fractionation of cellular components of platelets by differential centrifugation and gel filtration chromatography reveals that the high-affinity binding sites in these cells are also associated with membranous materials. A substantial number of the low-affinity binding sites can be traced t o platelet actin. The binding of cytochalasin B to actin is consistent with the alteration of intrinsic viscosity and morphology of actin filaments in vitro by the compound at concentrations of around 1 O-' -1 0-4 M. The interaction of cytochalasin B with actin may account for its inhibitory effect on various forms of cell motility.lo-' M) and a class of low-affinity sites
I NTRODUCTI ONIn recent years there has been much interest in the fungal metabolite cytochalasin B because of its rapid and reversible effects on a large number of biological processes (for reviews, see refs. 1-3). These effects can be classified into two groups. At low concentrations (around lop7 M), cytochalasin B inhibits transport of sugars into various types of mammalian cells (4-9). At higher concentrations (10-6-10-4 M) it inhibits various forms of cell motility, such as cytokinesis, cell locomotion, phagocytosis, cytoplasmic streaming, and blood clot retraction (1). Evidence suggests that inhibition of motility is not merely a secondary effect of glucose deprivation (6,7,10,11).The molecular basis of action of cytochalasin B is unknown. Schroeder (12) and Wessells et al.(1) concluded from work involving electron microscopy that inhibition of cell motility by the drug may be related t o the apparent disruption of microfilaments in the cell. The more recent observations that cytochalasin B inhibits sugar transport suggest that the plasma membrane may contain one or more receptors for the drug; indeed, it